Displaying 271 - 280 of 631
Co-sponsored by Endocrine Society, American Society of Andrology, European Society for Pediatric Endocrinology, European Society of Endocrinology, Pediatric Endocrine Society, and World Professional Association for Transgender Health.
This 2017 guideline‒led by the Endocrine Society and co-sponsored with AACE, American Society of Andrology, European Society for Pediatric Endocrinology, European Society of Endocrinology, Pediatric Endocrine Society, and World Professional Association for Transgender Health‒is an update of the 2009 Endocrine Society guideline on endocrine treatment…
more
These six case discussions present clinical vignettes to illustrate some of the key recommendations for diagnosis, treatment, and long-term management of transgender children and adults in the Endocrine Society's 2017 guideline, co-sponsored by AACE, on endocrine treatment of persons with gender dysphoria/gender incongruence.
Read Consensus Statement moreThis statement addresses the prevalence of macroprolactin in patients with hyperprolactinemia and macroprolactin’s relevance regarding clinical decision-making about laboratory testing, imaging, and pharmacologic or surgical treatment.
Read Consensus Statement moreThis statement addresses neuroendocrine evaluation, testing, and management of patients with traumatic brain injury‒induced hypopituitarism or those at risk for hypopituitarism.
Read Consensus Statement moreThis statement employs case studies to discuss evaluation, early diagnosis, surgical treatment, and ongoing management of endocrinopathies in patients with multiple endocrine neoplasia, type 2.
Read Consensus Statement moreCarcinoid tumors, which most commonly originate from the small intestine, are either referred to as small intestinal neuroendocrine tumors or midgut carcinoids. This statement addresses diagnostics and therapeutics for patients with midgut carcinoids and provides an overview of multidisciplinary care to improve quality of life, treatment outcomes, and survival.
Read Consensus Statement moreThis statement addresses incidental detection of pancreatic neuroendocrine tumors, imaging-based characterization for differential diagnoses, prognosis, and appropriate management.
Read Consensus Statement moreThe American Medical Association (AMA) is undertaking a new national study supported by AACE, along with
172 healthcare organizations, to collect representative data on physician practice expenses. The aim of the Physician Practice Information Survey is to better understand the costs faced by today’s physician practices to support physician payment advocacy. The study will serve as an opportunity to communicate accurate financial information to policymakers, including members of Congress and the Centers…
more
Together, We Are AACE!
Welcome to AACE’s Fellows’ Clinical Corner — your one-stop hub for evidence-based training to prepare for board review, continuing medical education, and the latest clinical endocrinology resources for your practice and patients. Below we’ve listed our most popular resources for you to take advantage of.
Discover the benefits of being an AACE fellow!AACE CEO Johnnie White, MBA, CAE, CMP Fellow, interviews Dr. Kayla Patel, the 2024-2025 AACE Fellow-in-Training (FIT) Board Representative, about her experience on the AACE…
more
Access our diabetes courses featuring the latest advancements and information on improving diabetes diagnosis and treatment.
Click
here to access
The GLP-1 RA's Role in the Management of Diabetes: Tools for the Primary Care Professional presentation slides.
Intensifying Diabetes Therapies Live Presentation Schedule
Live Presentation Schedule
MeetingPresentation DateRegistration Site…
more
